FLT3 and acute myeloid leukemia: In combination with the study from Sato et al. [25], reporting that FLT3 ligand in plasma of FLT3-ITD AML patients is highly increased during intensive chemotherapy, this could be a plausible mechanism for FLT3 signaling pathway to be involved in therapy resistance of leukemic cells.